Precision therapies in the epilepsies.

On demand webinar

Dr. George Busby, CSO & Co-founder of Allelica (300 × 214 px) (1920 × 800 px) (1920 × 1080 px) (1)

13 October 2021

Enabling Genomic Medicine (EGM) 2021: Best practice in genomic analysis

During Congenica's Enabling Genomic Medicine 2021 virtual event, Professor Norman Delanty, FRCPI, Consultant Neurologist, Beaumont Hospital, School of Pharmacy and Biomolecular Sciences, FutureNeuro Research Centre, Royal College of Surgeons in Ireland, Dublin presented:  

 

Precision therapies in the epilepsies

 

Enter your details to watch this complimentary webinar
CE 60px-Conformité_Européenne - WHITEISO 27001 Certified British Assessment Bureau - Certificate No. 205723 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2022 Congenica Ltd, Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.